Drug Approval | June 28, 2024
Eugia SEZ’s injectable facility gets EIR from USFDA
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
10th edition of the event is scheduled to be held during May 30-June 1 at Hitex, Hyderabad
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Eugia Pharma Specialities restarts production at terminally sterilized product lines
The facility will accommodate over 1,500 employees
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The CDCCs are strategically positioned in regions identified as high-impact areas
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Subscribe To Our Newsletter & Stay Updated
